Stapokibart
Stapokibart is a biological therapy with 8 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 1 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
3
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
1 of 1 finished
0.0%
0 ended early
2
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Study on the Treatment of Adolescent Patients With Seasonal Allergic Rhinitis
A Study of Stapokibart Injection in Patients With Atopic Dermatitis (AD)
A Study of Stapokibart Injection in Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Study on the Treatment of Prurigo Nodularis With Stapokibart Injection
Preoperative Stapokibart for Endoscopic Sinus Surgery in Chronic Rhinosinusitis With Nasal Polyps
Clinical Trials (8)
Study on the Treatment of Adolescent Patients With Seasonal Allergic Rhinitis
A Study of Stapokibart Injection in Patients With Atopic Dermatitis (AD)
A Study of Stapokibart Injection in Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Study on the Treatment of Prurigo Nodularis With Stapokibart Injection
Preoperative Stapokibart for Endoscopic Sinus Surgery in Chronic Rhinosinusitis With Nasal Polyps
A Prospective Study of Stapokibart Injection in Patients With Seasonal Allergic Rhinitis (SAR)
Efficacy and Safety of Stapokibart for Primary Cutaneous Amyloidosis
A Cohort Study on Biomarkers to Predict the Efficacy of Biologics for Chronic Rhinosinusitis with Nasal Polyps
All 8 trials loaded
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 8